Martinez Osorio CA, Sopena Sutil R, Vilaseca Cabo A, Linares Espinos E, et al. Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With Apalutamide. Prostate 2025 Sep 4. doi: 10.1002/pros.70040.
PMID: 40904242